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The surveillance for enteric fever in Asia project (SEAP): Estimating the community burden of enteric fever
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Sabin Vaccine Institute, Washington, DC, USA Abstract: Background: The Surveillance for Enteric Fever in Asia Project (SEAP) is a phased multi-country, multi-site surveillance study designed to characterize the burden of enteric fever in selected settings in Bangladesh, Nepal, and Pakistan.
Objectives: SEAP Phase I is aimed to assess health facilities with potential to participate in phase II, and to inform the design of phase II. SEAP Phase II objectives are to use the study sites identified in phase 1 to characterize the burden of enteric fever in selected Asian settings, including clinical manifestations, severity of illness, longterm sequelae of illness, antimicrobial resistance patterns of enteric fever isolates, and cost of illness.
Methods: SEAP Phase I was a 2-year retrospective review of existing data. SEAP Phase II is a prospective study combining hospital-based and laboratory surveillance with healthcare utilization survey to estimate disease burden. Phase II will also include long-term follow-up of all blood culture confirmed cases to assess long-term sequelae, an economic evaluation to characterize the economic burden of enteric fever, and the description of the antimicrobial sensitivity profile. All positive specimens collected will be included in a bank of Salmonella bacterial strains isolated during the study period.
Results of Phase I: In Bangladesh, Salmonella typhi and S. paratyphi accounted for 29% and 5% of all blood cultures in children enrolled in the ongoing Invasive Bacterial Vaccine Preventable Diseases Surveillance. Forty-five percent were female. Fever, diarrhea, nausea/vomiting and abdominal pain were present in 100%, 30%, 29% and 10% of patients, respectively. In Pakistan, 81% and 29% of all microbiologically-confirmed enteric fever cases, were S. typhi and S. paratyphi, respectively. Thirty-six percent were female. Fever, diarrhea, nausea/vomiting and abdominal pain were present in 97%, 26%, 40% and 21% of patients, respectively.
Conclusion: Results of SEAP Phase I demonstrate the continued burden of typhoid fever illness in participating countries, and highlight the need for SEAP Phase II, a well-designed prospective study based on input of committed stakeholders to better quantify true burden of illness and severity. Ultimately, results of SEAP Phase II will inform policy recommendations for vaccine use, and facilitate the assessment of the impact of interventions.
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